User login
Getting Young Smokers to Quit
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Getting Young Smokers to Quit
Article PDF
Issue
Federal Practitioner - 29(7)
Publications
Page Number
e2
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(7)
Issue
Federal Practitioner - 29(7)
Page Number
e2
Page Number
e2
Publications
Publications
Article Type
Display Headline
Getting Young Smokers to Quit
Display Headline
Getting Young Smokers to Quit
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
The Risks of Opioid Treatment for Veterans, The Effect of Weight on Vasopressin Therapy, Diuretics and Cognitive Function in Elders, and more
Article Type
Changed
Thu, 09/01/2016 - 15:30
Display Headline
The Risks of Opioid Treatment for Veterans, The Effect of Weight on Vasopressin Therapy, Diuretics and Cognitive Function in Elders, and more
Article PDF
Issue
Federal Practitioner - 29(7)
Publications
Topics
Page Number
41
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(7)
Issue
Federal Practitioner - 29(7)
Page Number
41
Page Number
41
Publications
Publications
Topics
Article Type
Display Headline
The Risks of Opioid Treatment for Veterans, The Effect of Weight on Vasopressin Therapy, Diuretics and Cognitive Function in Elders, and more
Display Headline
The Risks of Opioid Treatment for Veterans, The Effect of Weight on Vasopressin Therapy, Diuretics and Cognitive Function in Elders, and more
Sections
Disallow All Ads
Article PDF Media
Document
Votrient Approved for Soft Tissue Sarcoma
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Votrient Approved for Soft Tissue Sarcoma
Article PDF
Issue
Federal Practitioner - 29(6)
Publications
Page Number
e2
Legacy Keywords
Votrient, soft-tissue sarcomaVotrient, soft-tissue sarcoma
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(6)
Issue
Federal Practitioner - 29(6)
Page Number
e2
Page Number
e2
Publications
Publications
Article Type
Display Headline
Votrient Approved for Soft Tissue Sarcoma
Display Headline
Votrient Approved for Soft Tissue Sarcoma
Legacy Keywords
Votrient, soft-tissue sarcomaVotrient, soft-tissue sarcoma
Legacy Keywords
Votrient, soft-tissue sarcomaVotrient, soft-tissue sarcoma
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
A Dangerous Mix: Opioids, Sedatives, and Alcohol; UI Drugs Benefit Fewer Than Thought; Time to Switch to Sublingual Immunotherapy?
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
A Dangerous Mix: Opioids, Sedatives, and Alcohol; UI Drugs Benefit Fewer Than Thought; Time to Switch to Sublingual Immunotherapy?
Article PDF
Issue
Federal Practitioner - 29(6)
Publications
Page Number
39
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(6)
Issue
Federal Practitioner - 29(6)
Page Number
39
Page Number
39
Publications
Publications
Article Type
Display Headline
A Dangerous Mix: Opioids, Sedatives, and Alcohol; UI Drugs Benefit Fewer Than Thought; Time to Switch to Sublingual Immunotherapy?
Display Headline
A Dangerous Mix: Opioids, Sedatives, and Alcohol; UI Drugs Benefit Fewer Than Thought; Time to Switch to Sublingual Immunotherapy?
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Timing IG Therapy, A Safe Choice for OA Pain
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Timing IG Therapy, A Safe Choice for OA Pain
Article PDF
Issue
Federal Practitioner - 29(5)
Publications
Page Number
34
Legacy Keywords
Osteoarthritis, OA pain, immunoglobulins, topical diclofenac gel, septic shock, sepsis, IVIGsOsteoarthritis, OA pain, immunoglobulins, topical diclofenac gel, septic shock, sepsis, IVIGs
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(5)
Issue
Federal Practitioner - 29(5)
Page Number
34
Page Number
34
Publications
Publications
Article Type
Display Headline
Timing IG Therapy, A Safe Choice for OA Pain
Display Headline
Timing IG Therapy, A Safe Choice for OA Pain
Legacy Keywords
Osteoarthritis, OA pain, immunoglobulins, topical diclofenac gel, septic shock, sepsis, IVIGsOsteoarthritis, OA pain, immunoglobulins, topical diclofenac gel, septic shock, sepsis, IVIGs
Legacy Keywords
Osteoarthritis, OA pain, immunoglobulins, topical diclofenac gel, septic shock, sepsis, IVIGsOsteoarthritis, OA pain, immunoglobulins, topical diclofenac gel, septic shock, sepsis, IVIGs
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
When Endometrial Surgery Isn't Enough
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
When Endometrial Surgery Isn't Enough
Article PDF
Issue
Federal Practitioner - 29(4)
Publications
Page Number
e2
Legacy Keywords
Endometriosis, endometrial surgeryEndometriosis, endometrial surgery
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(4)
Issue
Federal Practitioner - 29(4)
Page Number
e2
Page Number
e2
Publications
Publications
Article Type
Display Headline
When Endometrial Surgery Isn't Enough
Display Headline
When Endometrial Surgery Isn't Enough
Legacy Keywords
Endometriosis, endometrial surgeryEndometriosis, endometrial surgery
Legacy Keywords
Endometriosis, endometrial surgeryEndometriosis, endometrial surgery
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
A Gender Paradox in Fibrinolysis; PPIs and Hip Fracture: Evaluating the Risk; How Long Do the Effects of Tyrosine Kinase Inhibitors Last?
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
A Gender Paradox in Fibrinolysis; PPIs and Hip Fracture: Evaluating the Risk; How Long Do the Effects of Tyrosine Kinase Inhibitors Last?
Article PDF
Issue
Federal Practitioner - 29(4)
Publications
Page Number
45
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(4)
Issue
Federal Practitioner - 29(4)
Page Number
45
Page Number
45
Publications
Publications
Article Type
Display Headline
A Gender Paradox in Fibrinolysis; PPIs and Hip Fracture: Evaluating the Risk; How Long Do the Effects of Tyrosine Kinase Inhibitors Last?
Display Headline
A Gender Paradox in Fibrinolysis; PPIs and Hip Fracture: Evaluating the Risk; How Long Do the Effects of Tyrosine Kinase Inhibitors Last?
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Drug Approved for Toxic Levels of Methotrexate
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Drug Approved for Toxic Levels of Methotrexate
Article PDF
Issue
Federal Practitioner - 29(3)
Publications
Page Number
e2
Legacy Keywords
Methotrexate, chemotherapy, glucarpidase, kidney failure, livewr failureMethotrexate, chemotherapy, glucarpidase, kidney failure, livewr failure
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(3)
Issue
Federal Practitioner - 29(3)
Page Number
e2
Page Number
e2
Publications
Publications
Article Type
Display Headline
Drug Approved for Toxic Levels of Methotrexate
Display Headline
Drug Approved for Toxic Levels of Methotrexate
Legacy Keywords
Methotrexate, chemotherapy, glucarpidase, kidney failure, livewr failureMethotrexate, chemotherapy, glucarpidase, kidney failure, livewr failure
Legacy Keywords
Methotrexate, chemotherapy, glucarpidase, kidney failure, livewr failureMethotrexate, chemotherapy, glucarpidase, kidney failure, livewr failure
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
Diabetes Drug Helps With Weight Loss
Article Type
Changed
Tue, 05/03/2022 - 15:58
Display Headline
Diabetes Drug Helps With Weight Loss
Article PDF
Issue
Federal Practitioner - 29(3)
Publications
Topics
Page Number
42
Legacy Keywords
incretin mimetic, weight loss, glucagon-like peptide, obesityincretin mimetic, weight loss, glucagon-like peptide, obesity
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(3)
Issue
Federal Practitioner - 29(3)
Page Number
42
Page Number
42
Publications
Publications
Topics
Article Type
Display Headline
Diabetes Drug Helps With Weight Loss
Display Headline
Diabetes Drug Helps With Weight Loss
Legacy Keywords
incretin mimetic, weight loss, glucagon-like peptide, obesityincretin mimetic, weight loss, glucagon-like peptide, obesity
Legacy Keywords
incretin mimetic, weight loss, glucagon-like peptide, obesityincretin mimetic, weight loss, glucagon-like peptide, obesity
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document
CLEOPATRA Study and MBC
Article Type
Changed
Thu, 12/15/2022 - 15:09
Display Headline
CLEOPATRA Study and MBC
Article PDF
Issue
Federal Practitioner - 29(3)
Topics
Page Number
42
Legacy Keywords
trastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumabtrastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumab
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 29(3)
Issue
Federal Practitioner - 29(3)
Page Number
42
Page Number
42
Topics
Article Type
Display Headline
CLEOPATRA Study and MBC
Display Headline
CLEOPATRA Study and MBC
Legacy Keywords
trastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumabtrastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumab
Legacy Keywords
trastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumabtrastuzumab, anti-human epidermal growth factor receptor 2, metastatic breast cancer, HER2, CLEOPATRA Study, pertuzumab
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document